沃森生物

- 300142

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
沃森生物(300142) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入46,225.77282,144.13214,134.62143,334.8659,975.36
营业收入46,225.77282,144.13214,134.62143,334.8659,975.36
二、营业总成本42,665.05253,177.41175,603.15117,865.5646,214.98
营业成本13,181.5857,299.2944,062.4328,672.8311,351.88
营业税金及附加358.421,887.971,373.81934.38417.34
销售费用16,433.7997,883.0768,070.0850,021.8021,045.57
管理费用7,077.9742,154.9821,991.3112,316.846,178.56
财务费用-1,077.08-5,702.38-3,005.02-2,776.53-1,480.44
研发费用6,690.3759,654.4743,110.5428,696.258,702.06
资产减值损失----------
公允价值变动收益1,413.73-9,833.91-9,369.01-10,200.98-8,481.79
投资收益-13.63502.59489.69365.448.68
其中:对联营企业和合营企业的投资收益-13.6313.017.480.138.68
汇兑收益----------
三、营业利润-1,357.619,667.4128,608.3018,841.675,964.92
加:营业外收入65.8712,692.5712,692.4112,692.410.01
减:营业外支出185.293,909.773,921.793,764.75239.60
其中:非流动资产处置损失----------
四、利润总额-1,477.0218,450.2137,378.9227,769.325,725.32
减:所得税费用491.251,010.422,314.832,017.711,894.10
五、净利润-1,968.2717,439.7935,064.0925,751.613,831.22
归属于母公司所有者的净利润264.6214,216.0425,635.8617,056.051,412.75
少数股东损益-2,232.893,223.759,428.238,695.572,418.47
六、每股收益
基本每股收益(元/股)0.00170.08890.16030.10660.0088
稀释每股收益(元/股)0.00170.08890.16030.10660.0088
七、其他综合收益---4,590.00------
八、综合收益总额-1,968.2712,849.7935,064.0925,751.613,831.22
归属于母公司所有者的综合收益总额264.629,626.0425,635.8617,056.051,412.75
归属于少数股东的综合收益总额-2,232.893,223.759,428.238,695.572,418.47
下载全部历史数据到excel中 返回页顶